Related Experiment Videos
Maternal phenylketonuria (PKU)--a review
W B Hanley1, J T Clarke, W Schoonheyt
1Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Clinical Biochemistry
|June 1, 1987
Summary
Untreated maternal phenylketonuria (PKU) severely damages fetuses, causing intellectual disability and birth defects. Early dietary intervention significantly reduces these risks, highlighting the need for widespread PKU screening.
Area of Science:
- Medical Genetics
- Maternal-Fetal Medicine
- Metabolic Disorders
Background:
- Maternal phenylketonuria (PKU) presents a significant risk of fetal damage.
- Untreated PKU in mothers leads to high rates of offspring intellectual disability, microcephaly, and congenital anomalies.
Purpose of the Study:
- To review the incidence of fetal damage in maternal PKU.
- To evaluate the effectiveness of dietary interventions for maternal PKU.
- To recommend screening strategies for maternal PKU.
Main Methods:
- Review of existing literature on maternal PKU and its outcomes.
- Analysis of data from treated and untreated maternal PKU cases.
- Examination of outcomes from a collaborative maternal PKU study.
Main Results:
- Classical untreated maternal PKU results in 92% intellectual disability, 73% microcephaly, and 40% growth retardation in offspring.
- Low phenylalanine diets during pregnancy drastically reduce fetal defect incidence.
- Early dietary treatment, especially preconceptionally, shows promising results.
Conclusions:
- Strict dietary management of maternal PKU is crucial for preventing fetal complications.
- Prenatal and premarital screening for maternal PKU is recommended for future generations.
- Close monitoring of maternal and fetal nutrition is essential during dietary therapy.